je.st
news
Tag: high
AC-DC Power Supplies deliver full output at high temperatures.
2015-04-24 14:31:06| Industrial Newsroom - All News for Today
Featuring fanless, conduction-cooled design, LCC600 Series delivers full 600 W power output across wide operating temperature of -40 to +85°C. Universal input of 90–264 Vac with optional 180–305 Vac input enables worldwide use without adjustment. First models available provide single 28 or 48 Vdc output and 5 V standby voltage output. Housed in sealed 4 x 9 in. enclosure with optional IP65 protection, 1U power supplies provide typ efficiency of 93% and are suited for indoor/outdoor use.
Tags: full
high
power
supplies
High Pressure Piston Pumps produce minimal pulsation.
2015-04-24 14:31:06| Industrial Newsroom - All News for Today
Designed with automatic pressure compensation and pulse dampener, LS Class single-headed, positive displacement piston pumps employ micro-stepping motor technology. Standard fluid path materials are stainless steel and PEEK (titanium optional); jacketed heads are available for temperature-controlled processes. Available in 5, 10, and 40 mL/min versions, products offer pressure capability up to 6,000 psi, chemically resistant drip tray, leak sensor, and RS-232 and Micro USB 2.0 ports.
Tags: high
produce
pressure
minimal
Very High Performance DSP Module Family, Based on Intel Xeon Processor D, Debuted by Curtiss-Wright
2015-04-24 12:31:12| Industrial Newsroom - All News for Today
New rugged 3U CHAMP-XD1 and 6U CHAMP-XD2 OpenVPX modules feature extremely fast DDR4 memory, 10/40 Gigabit Ethernet, and PCIe Gen 3 interconnects ASHBURN, Va. Curtiss-Wright Corporation (NYSE: CW) today announced that its Defense Solutions division has launched a new family of rugged DSP engine modules that is...
Tags: high
based
family
performance
Mercks Pivotal Phase 3 C-EDGE Program Evaluating Grazoprevir/Elbasvir Shows High Sustained Virologic Responses Across Broad Range of Patients with Chronic Hepatitis C Virus Infection
2015-04-24 07:00:00| Merck.com - Research & Development News
Dateline City: VIENNA Data Sets Include Treatment-Nave, Treatment-Experienced and HIV Co-Infected Patients with Chronic Hepatitis C Virus Genotypes 1, 4 or 6 Infection Merck Remains on Track to Submit New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) in First Half of 2015 VIENNA--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the first presentations of data from the companys ongoing C-EDGE pivotal Phase 3 clinical trial program evaluating the investigational once-daily tablet grazoprevir/elbasvir (100mg/50mg) in patients with or without cirrhosis who are infected with chronic hepatitis C virus (HCV) genotypes 1, 4 or 6 (GT1, 4 or 6).1 Patients in both the HCV infected, treatment-nave (C-EDGE TN), and HIV/HCV co-infected, treatment-nave (C-EDGE CO-INFXN
Tags: high
range
program
shows
Custom MMIC's New GaN LNA Meets Need For High RF Power Survivability
2015-04-24 06:16:56| rfglobalnet Home Page
Custom MMIC, a developer of performance-driven monolithic microwave integrated circuits (MMICs), is pleased to announce the addition of the CMD219C4, a new GaN low-noise amplifier, to their standard product catalog.
Sites : [539] [540] [541] [542] [543] [544] [545] [546] [547] [548] [549] [550] [551] [552] [553] [554] [555] [556] [557] [558] next »